These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957 [TBL] [Abstract][Full Text] [Related]
4. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. Murphy MF; Metcalfe P; Waters AH; Ord J; Hambley H; Nicolaides K Blood; 1993 Apr; 81(8):2174-9. PubMed ID: 8471776 [TBL] [Abstract][Full Text] [Related]
5. Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia. Sainio S; Teramo K; Kekomäki R Transfus Med; 1999 Dec; 9(4):321-30. PubMed ID: 10583886 [TBL] [Abstract][Full Text] [Related]
6. Neonatal alloimmune thrombocytopenia: antenatal management. Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864 [TBL] [Abstract][Full Text] [Related]
7. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families. Kanhai HH; Porcelijn L; van Zoeren D; Klumper F; Viëtor H; Meerman RH; Brand A Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):67-73. PubMed ID: 8886684 [TBL] [Abstract][Full Text] [Related]
8. The management of feto-maternal alloimmune thrombocytopenia: report of three cases. Paternoster DM; Cester M; Memmo A; Scandellari R; Fabris F; Girolami A J Matern Fetal Neonatal Med; 2006 Aug; 19(8):517-20. PubMed ID: 16966118 [TBL] [Abstract][Full Text] [Related]
9. [Prenatal management of fetuses with alloimmune thrombocytopenia]. Kroll H; Kiefel V; Giers G; Kaplan C; Murphy M; Waters A; Mueller-Eckhardt C Beitr Infusionsther Transfusionsmed; 1996; 33():150-5. PubMed ID: 8974688 [TBL] [Abstract][Full Text] [Related]
10. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107 [TBL] [Abstract][Full Text] [Related]
11. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Spencer JA; Burrows RF Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):45-55. PubMed ID: 11284646 [TBL] [Abstract][Full Text] [Related]
12. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period]. Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591 [TBL] [Abstract][Full Text] [Related]
14. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia. Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591 [TBL] [Abstract][Full Text] [Related]
15. Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT. Kaplan C; Murphy MF; Kroll H; Waters AH Br J Haematol; 1998 Jan; 100(1):62-5. PubMed ID: 9450792 [TBL] [Abstract][Full Text] [Related]
16. HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia. Ghevaert C; Campbell K; Stafford P; Metcalfe P; Casbard A; Smith GA; Allen D; Ranasinghe E; Williamson LM; Ouwehand WH Transfusion; 2007 Jul; 47(7):1296-305. PubMed ID: 17581167 [TBL] [Abstract][Full Text] [Related]
17. The management of alloimmune neonatal thrombocytopenia. Blanchette VS; Johnson J; Rand M Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040 [TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage. Kanhai HH; van den Akker ES; Walther FJ; Brand A Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976 [TBL] [Abstract][Full Text] [Related]